Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

NCT01748149 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas

Interventions

DRUG: Vemurafenib

Sponsor

University of California, San Francisco

Collaborators

[object Object]